{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/menopause/diagnosis/assessment/","result":{"pageContext":{"chapter":{"id":"a84016e1-b7af-55f9-b1f8-c85ff76cfc93","slug":"assessment","fullItemName":"Assessment","depth":2,"htmlHeader":"<!-- begin field 8cb600de-7c86-4fdc-91e4-f2d544fb7d82 --><h2>How should I assess a woman with menopausal symptoms?</h2><!-- end field 8cb600de-7c86-4fdc-91e4-f2d544fb7d82 -->","summary":"","htmlStringContent":"<!-- begin item 2f4a38c8-fcff-4e23-8897-ab98ebd72d84 --><!-- begin field 932a7135-e07d-4577-b806-613767479669 --><p><strong>If a woman has suspected <a class=\"topic-reference internal-reference\" href=\"/topics/menopause/background-information/definition/\">menopause</a>, <a class=\"topic-reference internal-reference\" href=\"/topics/menopause/background-information/definition/\">perimenopause</a>, or <a class=\"topic-reference internal-reference\" href=\"/topics/menopause/background-information/definition/\">premature ovarian insufficiency</a> (POI):</strong></p><ul><li><strong>Ask about:</strong><ul><li>The <a class=\"topic-reference internal-reference\" href=\"/topics/menopause/diagnosis/diagnosis-of-menopause-perimenopause/\">symptoms</a> of menopause, including nature, frequency, duration, time of day, and their severity and impact on quality of life.</li><li>Other potential causes of amenorrhoea, including pregnancy. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/amenorrhoea/\">Amenorrhoea</a> for more information.</li><li>Lifestyle factors, such as smoking, alcohol, exercise, and nutrition.</li><li>The need for ongoing or future contraception. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-assessment/\">Contraception - assessment</a> for more information.</li><li>Smear status and engagement with national screening programmes (if appropriate). See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/cervical-screening/\">Cervical screening</a>, <a class=\"topic-reference external-reference\" href=\"/topics/breast-screening/\">Breast screening</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/bowel-screening/\">Bowel screening</a> for more information.</li><li>Family history including premature menopause or POI, venous thromboembolism, or hormone-dependent cancer including breast cancer. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/breast-cancer-managing-fh/\">Breast cancer - managing FH</a> for more information.</li><li>Her treatment goals, including non-pharmacological, non-hormonal, or hormonal drug options.</li><li>Previous treatments tried, effectiveness, and tolerability (if any).</li><li>Current medications that may affect the choice of treatments available.</li><li>Co-morbid conditions that may affect the choice and safety of <a class=\"topic-reference internal-reference\" href=\"/topics/menopause/management/management-of-menopause-perimenopause-or-premature-ovarian-insufficiency/#hormone-replacement-therapy-hrt\">hormonal treatment</a> options, depending on the woman's wishes, such as:<ul><li>History of, or increased risk of, cardiovascular disease, hypertension, diabetes mellitus, venous thromboembolism, or stroke disease. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/cvd-risk-assessment-management/\">CVD risk assessment and management</a>, <a class=\"topic-reference external-reference\" href=\"/topics/hypertension-not-diabetic/\">Hypertension - not diabetic</a>, <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-2/\">Diabetes - type 2</a>, <a class=\"topic-reference external-reference\" href=\"/topics/deep-vein-thrombosis/\">Deep vein thrombosis</a>, <a class=\"topic-reference external-reference\" href=\"/topics/pulmonary-embolism/\">Pulmonary embolism</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/stroke-tia/\">Stroke and TIA</a> for more information.</li><li>History of, or increased risk of, hormone-dependent cancer including breast, endometrial, and ovarian cancer.</li><li>Previous medical or surgical treatment, including chemotherapy, radiotherapy, hysterectomy, and/or bilateral oophorectomy.</li></ul></li><li>Bone health and assess risk of osteoporosis. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/osteoporosis-prevention-of-fragility-fractures/\">Osteoporosis - prevention of fragility fractures</a> for more information.</li></ul></li><li><strong>Examine the woman:</strong><ul><li>Check blood pressure and body mass index (BMI).</li><li>If there is a sudden change in menstrual pattern, intermenstrual bleeding, postcoital bleeding, or postmenopausal bleeding — assess appropriately and arrange an urgent 2-week referral if a gynaecological cancer is suspected. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/gynaecological-cancers-recognition-referral/\">Gynaecological cancers - recognition and referral</a> for more information.</li></ul></li></ul><!-- end field 932a7135-e07d-4577-b806-613767479669 --><!-- end item 2f4a38c8-fcff-4e23-8897-ab98ebd72d84 -->","topic":{"id":"69003588-b736-585d-8a5d-7ca0e916caa5","topicId":"f75fa6a7-10c6-4887-9cf1-3ea14d7f353c","topicName":"Menopause","slug":"menopause","lastRevised":"Last revised in November 2020","chapters":[{"id":"0359e5fa-1342-5767-a4da-2f8b5cd2b6db","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"c978ff88-dda8-5879-a0ac-9b09182d81d1","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"d381eed9-6611-5263-a3be-b46ec9f02058","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"ddcba55c-566e-5433-8dce-2e5f5cee0ba4","slug":"changes","fullItemName":"Changes"},{"id":"e521b2f5-34d4-580f-b63d-a1ec2d0c13a3","slug":"update","fullItemName":"Update"}]},{"id":"ab5690cf-81b4-5fa9-b69f-27abc2e034a3","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"c0f45ff8-442c-5027-922e-12d108200960","slug":"goals","fullItemName":"Goals"},{"id":"8459ae09-bdf2-5d0d-9728-538e93d05a8f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"43027e52-84ef-53fa-88c5-a84289154e48","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4620ee3c-97ae-5f9f-8bac-fc8497801cdb","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"b26fb3cf-562a-595a-8f9e-92fd752d2e6b","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"10c1cb80-22cc-5889-8e30-35cf1a9843bf","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"18c173af-ec8a-571c-be49-d894f0bec50b","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"8e86f5f5-2343-5ea3-8d0d-7dda791a066e","slug":"definition","fullItemName":"Definition"},{"id":"17295b39-3f33-5e75-8d8a-1fc32c2efb70","slug":"causes","fullItemName":"Causes"},{"id":"5b768dab-f7db-50c3-8686-0d363f36e74d","slug":"prevalence","fullItemName":"Prevalence"},{"id":"698848d3-f122-5e5a-acc8-98518854f51b","slug":"complications","fullItemName":"Complications"},{"id":"647a928d-775d-5b0b-b577-b695140b26a3","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"00aeafb7-f9e4-5fd2-8fd2-57bd7fd333d8","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"d68ce2dd-2971-5c66-b22c-df0db848cf06","slug":"diagnosis-of-menopause-perimenopause","fullItemName":"Diagnosis of menopause and perimenopause"},{"id":"8b9c8208-91c2-5751-8a76-dc9461736050","slug":"diagnosis-of-premature-ovarian-insufficiency","fullItemName":"Diagnosis of premature ovarian insufficiency"},{"id":"a84016e1-b7af-55f9-b1f8-c85ff76cfc93","slug":"assessment","fullItemName":"Assessment"},{"id":"6c51a87c-f89c-5e58-b495-39506bc70e62","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"649507f8-7b95-5740-9833-fee7c5bff092","fullItemName":"Management","slug":"management","subChapters":[{"id":"9c13d541-f2ee-5d0a-a174-cd7c7b4aa392","slug":"management-of-menopause-perimenopause-or-premature-ovarian-insufficiency","fullItemName":"Scenario: Management of menopause, perimenopause, or premature ovarian insufficiency"}]},{"id":"7d937659-3134-52f9-8742-b90a6ffb1f1f","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"19b6008a-dd02-5fdb-b146-5cb427bb1f29","slug":"hormone-replacement-therapy-hrt","fullItemName":"Hormone replacement therapy (HRT)"}]},{"id":"ff6b5c36-2033-50a7-9c74-c9e46f1c8242","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"c9280136-8c1b-5890-96e2-c8f14078bb5f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"4f9c2c0d-8ea0-5048-8ae4-0b2517bed5ca","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"4b187b70-dcd7-5e05-ac85-fd75204e2515","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b3e44a7a-44e1-5dec-bd9e-67a0cad5baca","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6e1b4175-c43f-53ce-8884-b9f1b5b39f58","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6e0d3a8f-c4c1-533c-b265-34d08681175b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"e6340cdd-13d8-5fde-912f-a3d2c50f305f","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"00aeafb7-f9e4-5fd2-8fd2-57bd7fd333d8","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"97cac9f3-279c-507e-8e87-69ea575b64b6","slug":"basis-for-recommendation-e1e","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 9f437ba7-fdc4-4d33-aadd-ba9fc96178ed --><h3>Basis for recommendation</h3><!-- end field 9f437ba7-fdc4-4d33-aadd-ba9fc96178ed -->","summary":null,"htmlStringContent":"<!-- begin item e1e5b25e-42f4-4775-897e-a9309e8c7d4a --><!-- begin field 0c88ca10-7fb0-46a3-aa78-a2ab5eec5243 --><p>The recommendations on assessment are based on the National Institute for Health and Care Excellence (NICE) clinical guidelines <em>Menopause</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">NICE, 2019</a>] and <em>Suspected cancer: recognition and referral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">NICE, 2017b</a>]; the European Menopause and Andropause Society (EMAS) position statements <em>Maintaining postreproductive health: a care pathway from the European Menopause and Andropause Society (EMAS)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Armeni, 2016</a>], <em>EMAS recommendations for conditions in the workplace for menopausal women</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Griffiths, 2016</a>], and <em>Predictors of premature and early natural menopause</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Mishra, 2019</a>]; the Endocrine Society clinical practice guideline <em>Treatment of symptoms of the menopause</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Stuenkel, 2015</a>]; the American Association of Clinical Endocrinologists (AACE) consensus publication <em>Medical guidelines for clinical practice for the diagnosis and treatment of menopause</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Goodman, 2011</a>]; the AACE and American College of Endocrinology (ACE) <em>Position statement on menopause - 2017 update</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Cobin, 2017</a>]; the North American Menopause Society position statements on non-hormonal management of vasomotor symptoms [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">North American Menopause Society, 2015</a>] and on hormonal therapy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">North American Menopause Society, 2018</a>]; the Faculty of Sexual and Reproductive Healthcare (FSRH) clinical guideline <em>Contraception for women aged over 40 years</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">FSRH, 2019</a>]; and expert opinion in a review article on hormonal treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Pinkerton, 2020</a>] and in a medical textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Rees, 2009</a>].</p><h5>Clinical features on history taking</h5><ul><li>The recommendation to assess the nature of menopausal symptoms and impact on quality of life is extrapolated from the EMAS position statement [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Griffiths, 2016</a>].</li><li>The recommendation to assess for other causes of amenorrhoea is based on the EMAS position statement [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Armeni, 2016</a>].</li><li>The recommendation to assess for lifestyle factors is based on the EMAS position statement [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Armeni, 2016</a>] and the AACE consensus publication, which notes that obesity and smoking can increase risk of venous thromboembolism, which in turn may affect the choice of treatment options available [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Goodman, 2011</a>].</li><li>The recommendation to assess the need for contraception is extrapolated from the FSRH clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">FSRH, 2019</a>].</li><li>The recommendation to assess smear status and engagement with other screening programmes is based on the EMAS position statement [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Armeni, 2016</a>] and the Endocrine Society clinical practice guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Stuenkel, 2015</a>].</li><li>The recommendation to assess family history including premature menopause and premature ovarian insufficiency (POI) is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">NICE, 2019</a>] and the EMAS position statement, which notes strong genetic predictors of premature and early menopause [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Mishra, 2019</a>].</li><li>The recommendation to assess the woman's treatment goals is based on the NICE clinical guideline on menopause [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">NICE, 2019</a>].</li><li>The recommendation to assess co-morbid conditions that may affect choice of treatment options is based on the EMAS position statement [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Armeni, 2016</a>], the AACE consensus publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Goodman, 2011</a>], the AACE/ACE position statement [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Cobin, 2017</a>], the Endocrine Society clinical practice guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Stuenkel, 2015</a>], the North American Menopause Society position statement on hormonal therapy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">North American Menopause Society, 2018</a>], and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Pinkerton, 2020</a>].</li><li>The recommendation to assess bone health is based on the Endocrine Society clinical practice guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Stuenkel, 2015</a>].</li></ul><h5>Clinical features on examination</h5><ul><li>The recommendation to check blood pressure and body mass index (BMI) if considering hormonal treatment is based on the EMAS position statement [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">Armeni, 2016</a>].</li><li>The recommendation to assess appropriately if there is suspected gynaecological cancer is based on the NICE clinical guideline on suspected cancer [<a class=\"bibliography-reference internal-reference\" href=\"/topics/menopause/references/\">NICE, 2017b</a>].</li></ul><!-- end field 0c88ca10-7fb0-46a3-aa78-a2ab5eec5243 --><!-- end item e1e5b25e-42f4-4775-897e-a9309e8c7d4a -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}